Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $6.6 million.

  • China Pharma Holdings' Total Current Liabilities rose 3912.85% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year increase of 3912.85%. This contributed to the annual value of $5.0 million for FY2024, which is 2643.99% down from last year.
  • China Pharma Holdings' Total Current Liabilities amounted to $6.6 million in Q3 2025, which was up 3912.85% from $5.3 million recorded in Q2 2025.
  • China Pharma Holdings' Total Current Liabilities' 5-year high stood at $12.7 million during Q4 2022, with a 5-year trough of $4.7 million in Q2 2024.
  • Moreover, its 5-year median value for Total Current Liabilities was $8.4 million (2022), whereas its average is $8.5 million.
  • In the last 5 years, China Pharma Holdings' Total Current Liabilities plummeted by 5532.22% in 2024 and then surged by 3912.85% in 2025.
  • China Pharma Holdings' Total Current Liabilities (Quarter) stood at $10.5 million in 2021, then rose by 21.17% to $12.7 million in 2022, then plummeted by 46.46% to $6.8 million in 2023, then fell by 26.44% to $5.0 million in 2024, then soared by 32.0% to $6.6 million in 2025.
  • Its Total Current Liabilities was $6.6 million in Q3 2025, compared to $5.3 million in Q2 2025 and $5.1 million in Q1 2025.